. home.aspx

NEWS

home.aspx
   


US Capital Global Provides $8 Million Financing for Pioneering MedTech Company

August 09, 2019 / Virtual-Strategy Magazine

US Capital Global has provided $8 million in debt financing for a medical disease-testing kit company based in the Southeastern United States. Headquartered in San Francisco, US Capital Global provides sophisticated debt, equity, and investment products to lower middle market companies and investors. This expanding MedTech company aims to deliver earlier and more accurate testing for serious health conditions and diseases, such as prostate cancer, using pioneering, patented mitochondrial DNA biomarker technology. The firm sought growth capital and working capital to develop and bring to market its non-invasive disease-testing products. We are very pleased to have provided $8 million in debt financing for this MedTech firm, said Jeffrey Sweeney, Chairman and CEO at US Capital Global. As an early-stage company developing a portfolio of innovative and highly promising patent-protected products, the firm approached US Capital Global for a non-dilutive capital infusion of at least $5 millio...